ロード中...
In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia
There is a paucity of efficacious antimicrobials (especially oral) against clinically relevant species of Nocardia. To date, all species of Nocardia have been susceptible to linezolid, the first commercially available oxazolidinone. Tedizolid is a new oxazolidinone with previously reported improved...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700301/ https://ncbi.nlm.nih.gov/pubmed/28923878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01537-17 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|